Cargando…

Clinical and psychological status of patients with different types of juvenile arthritis

Detalles Bibliográficos
Autores principales:	Stepanenko, Natalia, Nikishina, Irina, Shelepina, Tatyana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184172/ http://dx.doi.org/10.1186/1546-0096-12-S1-P102

Ejemplares similares

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)

PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
por: Shelepina, TA, et al.
Publicado: (2013)

Medication therapy patients with juvenile idiopathic arthritis (JIA), who needed joint replacement in adult life
por: Shelepina, Tatiana A, et al.
Publicado: (2014)

Comparative characteristic of quality of life with patients suffering from juvenile idiopathic arthritis (JIA), attending school and taught at home
por: Shelepina, TA, et al.
Publicado: (2011)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
por: Stepanenko, NY
Publicado: (2011)

Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
por: Kaleda, Maria I, et al.
Publicado: (2014)

Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
por: Nikishina, I, et al.
Publicado: (2008)

A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present
por: Nikishina, Irina, et al.
Publicado: (2014)

PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
por: Kaleda, MI, et al.
Publicado: (2013)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
por: Arsenyeva, SV, et al.
Publicado: (2013)

Quality of life in patients with juvenile arthritis: adalimumab might make a difference
por: Denisova, Rina, et al.
Publicado: (2011)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
por: Arsenyeva, Svetlana V, et al.
Publicado: (2014)

PReS-FINAL-2039: Evaluation of local activity of wrists and finger joints damage in patients with juvenile idiopathic arthritis: the values of radiology methods
por: Alekseev, D, et al.
Publicado: (2013)

An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage
por: Nikishina, IP, et al.
Publicado: (2011)

Osteonecrosis of the femoral heads in patients with systemic onset juvenile idiopathic arthritis: comparison of the results of radiological and morphological methods
por: Alexeev, D, et al.
Publicado: (2011)

Juvenile idiopathic arthritis is a diagnosis of exclusion
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis
por: Stoustrup, Peter, et al.
Publicado: (2011)

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
por: Nikishina, IP, et al.
Publicado: (2013)

PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

Clinical and articular presentation of juvenile idiopathic arthritis
por: Ravichandran, R, et al.
Publicado: (2008)

TH17-phenotypes of juvenile idiopathic arthritis
por: Turtsevich, Inga Z, et al.
Publicado: (2014)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
por: Cohen, Jean-David, et al.
Publicado: (2012)

Genetic markers in clinical subtypes of juvenile idiopathic arthritis
por: Le Blay, Pierre, et al.
Publicado: (2011)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
por: Cimaz, Rolando, et al.
Publicado: (2011)

Juvenile Psoriatic Arthritis (JPsA) clinical features and outcome of 119 patients
por: Aviel, Y Butbul, et al.
Publicado: (2008)

PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis
por: Sørensen, SK
Publicado: (2013)

DIssociation of T lymphocyte subpopulations in patients with juvenile idiopathic arthritis
por: Minira, Bulegenova, et al.
Publicado: (2014)

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
por: Zhizho, Ye, et al.
Publicado: (2008)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
por: Sleptsova, TV, et al.
Publicado: (2011)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Performance of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients
por: Gutiérrez-Suárez, R, et al.
Publicado: (2008)

Responsiveness of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients
por: Gutiérrez-Suárez, R, et al.
Publicado: (2008)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
por: Solari, N, et al.
Publicado: (2008)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6f87sksfc6fnn2mn0attmujd5u